These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 34871332

  • 1. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
    Wang LT, Pereira LS, Kiyuka PK, Schön A, Kisalu NK, Vistein R, Dillon M, Bonilla BG, Molina-Cruz A, Barillas-Mury C, Tan J, Idris AH, Francica JR, Seder RA.
    PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
    [Abstract] [Full Text] [Related]

  • 2. The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo.
    Flores-Garcia Y, Wang LT, Park M, Asady B, Idris AH, Kisalu NK, Muñoz C, Pereira LS, Francica JR, Seder RA, Zavala F.
    PLoS Pathog; 2021 Nov; 17(11):e1010042. PubMed ID: 34748617
    [Abstract] [Full Text] [Related]

  • 3. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.
    Wang LT, Pereira LS, Flores-Garcia Y, O'Connor J, Flynn BJ, Schön A, Hurlburt NK, Dillon M, Yang ASP, Fabra-García A, Idris AH, Mayer BT, Gerber MW, Gottardo R, Mason RD, Cavett N, Ballard RB, Kisalu NK, Molina-Cruz A, Nelson J, Vistein R, Barillas-Mury C, Amino R, Baker D, King NP, Sauerwein RW, Pancera M, Cockburn IA, Zavala F, Francica JR, Seder RA.
    Immunity; 2020 Oct 13; 53(4):733-744.e8. PubMed ID: 32946741
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
    Livingstone MC, Bitzer AA, Giri A, Luo K, Sankhala RS, Choe M, Zou X, Dennison SM, Li Y, Washington W, Ngauy V, Tomaras GD, Joyce MG, Batchelor AH, Dutta S.
    Sci Rep; 2021 Mar 05; 11(1):5318. PubMed ID: 33674699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
    Espinosa DA, Gutierrez GM, Rojas-López M, Noe AR, Shi L, Tse SW, Sinnis P, Zavala F.
    J Infect Dis; 2015 Oct 01; 212(7):1111-9. PubMed ID: 25762791
    [Abstract] [Full Text] [Related]

  • 10. Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
    Murugan R, Scally SW, Costa G, Mustafa G, Thai E, Decker T, Bosch A, Prieto K, Levashina EA, Julien JP, Wardemann H.
    Nat Med; 2020 Jul 01; 26(7):1135-1145. PubMed ID: 32451496
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R, DeBot M, Porter M, Nikki J, Rein L, Spaccapelo R, Crisanti A, Wightman PD, Ockenhouse CF, Dutta S.
    PLoS One; 2014 Jul 01; 9(10):e111020. PubMed ID: 25343487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice.
    Palma C, Overstreet MG, Guedon JM, Hoiczyk E, Ward C, Karen KA, Zavala F, Ketner G.
    Vaccine; 2011 Feb 11; 29(8):1683-9. PubMed ID: 21199707
    [Abstract] [Full Text] [Related]

  • 16. Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite protein.
    Oyen D, Torres JL, Aoto PC, Flores-Garcia Y, Binter Š, Pholcharee T, Carroll S, Reponen S, Wash R, Liang Q, Lemiale F, Locke E, Bradley A, King CR, Emerling D, Kellam P, Zavala F, Ward AB, Wilson IA.
    PLoS Pathog; 2020 Mar 11; 16(3):e1008373. PubMed ID: 32150583
    [Abstract] [Full Text] [Related]

  • 17. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.
    Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, Meuleman P, Leroux-Roels G.
    J Clin Invest; 2014 Jan 11; 124(1):140-4. PubMed ID: 24292709
    [Abstract] [Full Text] [Related]

  • 18. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria.
    Wang LT, Hurlburt NK, Schön A, Flynn BJ, Flores-Garcia Y, Pereira LS, Kiyuka PK, Dillon M, Bonilla B, Zavala F, Idris AH, Francica JR, Pancera M, Seder RA.
    Cell Rep; 2022 Feb 15; 38(7):110367. PubMed ID: 35172158
    [Abstract] [Full Text] [Related]

  • 19. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
    Przysiecki C, Lucas B, Mitchell R, Carapau D, Wen Z, Xu H, Wang XM, Nahas D, Wu C, Hepler R, Ottinger E, Ter Meulen J, Kaslow D, Shiver J, Nardin E.
    Front Cell Infect Microbiol; 2012 Feb 15; 2():146. PubMed ID: 23226683
    [Abstract] [Full Text] [Related]

  • 20. Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies.
    Oludada OE, Costa G, Burn Aschner C, Obraztsova AS, Prieto K, Canetta C, Hoffman SL, Kremsner PG, Mordmüller B, Murugan R, Julien JP, Levashina EA, Wardemann H.
    EMBO Mol Med; 2023 Jun 07; 15(6):e17454. PubMed ID: 37082831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.